Pagano L, Paoletti S, Afa G, Marra R, Garcovich A, Bizzi B
Clin Rheumatol. 1985 Sep;4(3):286-9. doi: 10.1007/BF02031609.
The role of beta 2 microglobulin (beta 2-m) in Systemic Sclerosis (SS) has been evaluated. Twenty-four female patients have been examined: 15 of them were affected by acrosclerosis (Group 1) and 9 of them by diffuse sclerosis (Group 2). 46.6% of Group 1 and 44.4% of Group 2 had values significantly higher than normal controls. (P less than 0.01 and P less than 0.005 respectively). The authors deal with the validity of the use of B2-m as index of inflammatory activity of the disease.
已经评估了β2微球蛋白（β2-m）在系统性硬化症（SS）中的作用。对24名女性患者进行了检查：其中15名患有肢端硬化症（第1组），9名患有弥漫性硬化症（第2组）。第1组的46.6%和第2组的44.4%的值显著高于正常对照组。（分别为P<0.01和P<0.005）。作者探讨了将B2-m用作该疾病炎症活动指标的有效性。
